GCGiovanna Cotugno

Giovanna Cotugno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giovanna Cotugno has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition

    by Damiana Pieragostino, Ilaria Cicalini, Silvia Di Michele, Paola Fusilli, Giovanna Cotugno, Rossella Ferrante, Ines Bucci, Carlo Dionisi-Vici, Liborio Stuppia, Vincenzo De Laurenzi, et al.

    Phenylketonuria (PKU) is a rare autosomal recessive condition affecting about 1 in 10,000 people in the Europe, with a higher rate in some countries, like Ireland and Italy. In Italy, newborn screening (NBS) by MS/MS allows the diagnostic suspicion of PKU and its variants (Hyperphenylalaninemia (HPA), Tetrahydrobiopterin (BH4) synthesis deficiency, and Tetrahydrobiopterin (BH4) recycling deficiency) through the quantification of Phenylalanine (Phe) and the Phenylalanine/Tyrosine (Phe/Tyr) ratio in dried blood Spot (DBS) samples. Here, we report a case of an HPA whose suspicion was possible with expanded NBS, even if the normal-weight newborn was in total parenteral nutrition (TPN). It is known that TPN may present metabolic alterations, mainly for amino acids at NBS in MS/MS, frequently causing false positives. Actually, TPN is considered a special protocol in NBS, requiring several sample collections. In particular, a DBS sample is required before TPN, at basal time point (48 h after birth) and 72 h after the end of the procedure. In the case we report, even if the first DBS sample (before TPN) resulted negative, the repeated NBS tests revealed increased levels of Phe and dramatically high Phe/Tyr ratio. Thus, the newborn was recalled, and the NBS test was repeated several times before that HPA suspicion was confirmed by other specific biochemical tests. This case highlights the importance of Phe/Tyr ratio, only detectable by MS/MS analysis, in supporting the diagnostic suspicion during amino acids administration in the neonatal period.


  • P016 Impact of liver transplant on metabolic profiles in children with inborn errors of protein metabolism

    by G. Ranucci, D. Martinelli, A. Maiorana, A. Liguori, S. Bernabei, D. Liccardo, M. Candusso, G. Cotugno, C. Grimaldi, B. Goffredo, et al.

  • P015 Chronic liver involvement in urea cycle disorders on long term follow-up

    by G. Ranucci, G. Cotugno, A. Liguori, S. Bernabei, B. Goffredo, D. Martinelli, C. Dionisi-Vici

  • Adherence to diet and quality of life in patients with phenylketonuria

    by G Cotugno, R Nicolò, S Cappelletti, Bm Goffredo, C Dionisi Vici, V Di Ciommo

    Aim:  To investigate adherence to dietary treatment and quality of life (QoL) in patients with phenylketonuria (PKU).Methods:  In the setting of a tertiary paediatric hospital, 41 early‐treated patients affected by PKU aged more than 3 years old were enrolled in a cross‐sectional study. Three‐days dietary assessment, QoL questionnaires for patients Results:  Of 41 patients, 23 (56.1%) were considered adherent to the dietary prescriptions as their phenylalanine intake was less than prescribed. Phenylalanine intake was significantly in excess of prescribed if mothers had a lower level of education. Adherence was not correlated with age. Metabolic control was obtained in 41.5–51.2% of the patients depending on the target. QoL was reduced in children and adolescents. There was no significant correlation between adherence and QoL, except for the domains of Global Health and Family Activities (ρ = 0.42 and 0.46, respectively). The overall agreement between adherence and metabolic control varied according to different targets of metabolic control (51.2–65.9%).Conclusions:  It is necessary to improve the adherence to diet and the QoL in children and adolescents affected by PKU.